Who are Matinas BioPharma Holdings, Inc.'s main suppliers?

Matinas BioPharma Holdings, Inc. (MTNB) key suppliers include: RUTGERS-UNIVERSITY, BioNTech SE, BioNTech SE, ORANY, ORANY. View the full supplier network at chainsifter.com/chain/MTNB.

Who are Matinas BioPharma Holdings, Inc.'s major customers?

Matinas BioPharma Holdings, Inc. (MTNB) key customers include: X-GEN-PHARMACEUTICALS-INC, BioNTech SE, BioNTech SE, ORANY, ORANY. View the full customer network at chainsifter.com/chain/MTNB.

What sector is Matinas BioPharma Holdings, Inc. in?

Matinas BioPharma Holdings, Inc. (MTNB) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

MTNB Supply Chain: Matinas BioPharma Holdings, Inc. Supplier List & 13 Relationships

5Suppliers

5Customers

3Debt Items

20Related Chains

Matinas BioPharma Holdings, Inc. Suppliers

Ticker	Name	Confidence	Evidence
RUTGERS-UNIVERSITY	RUTGERS-UNIVERSITY	92%	we acquired a license from Rutgers University ("Rutgers") for certain patents related to the LNC Platform
BNTX	BioNTech SE	72%	contractors associated with Chemistry and Manufacturing Controls (CMC), pre-clinical and clinical activities and regulatory operations; ● expenses incurred under agreements with contract research org…
BNTX	BioNTech SE	72%	Reciprocal relationship from BNTX graph: Reciprocal relationship from MTNB graph: contractors associated with Chemistry and Manufacturing Controls (CMC), pre-clinical and clinical activities and regu…
ORANY	ORANY	72%	produce the clinical supplies of product necessary to conduct our previous clinical trials with MAT2203, we continue to explore relationships with well-respected third-party contract manufacturers fo…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from MTNB graph: produce the clinical supplies of product necessary to conduct our previous clinical trials with MAT2203, we continue…

Matinas BioPharma Holdings, Inc. Customers

Ticker	Name	Confidence	Evidence
X-GEN-PHARMACEUTICALS-INC	X-GEN-PHARMACEUTICALS-INC	85%	s), Rezzayo (rezafungin, marketed byCorMedix Therapeutics), Brexafemme (Ibrexafungerp marketed by GlaxoSmithKline) and amphotericin B deoxycholate (marketed by X-Gen Pharmaceuticals, Inc.). There cur…
BNTX	BioNTech SE	72%	. The lease impairment charges were included in the impairment charges of other assets line in the consolidated statement of operations and comprehensive loss for the year ended December 31, 2024. Th…
BNTX	BioNTech SE	72%	Reciprocal relationship from BNTX graph: Reciprocal relationship from MTNB graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MTNB graph: . The lease impairment charges were…
ORANY	ORANY	72%	produce the clinical supplies of product necessary to conduct our previous clinical trials with MAT2203, we continue to explore relationships with well-respected third-party contract manufacturers fo…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from MTNB graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from MTNB graph: Reciprocal relationship from ORAN…

Matinas BioPharma Holdings, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
MTNB-DEBT-11121	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2017-12-31.
MTNB-DEBT-11120	Warrants outstanding: 238000	90%	xbrl warrant detail from xbrl 2025-12-31.
MTNB-DEBT	Debt stack $1.4M	90%	Market cache reports total debt of $1.4M.

Matinas BioPharma Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Matinas BioPharma Holdings, Inc..

Matinas BioPharma Holdings, Inc. Ownership

Holder	Name	Confidence	Evidence
MTNB-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 28 tracked holders.

Matinas BioPharma Holdings, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
AZN	AstraZeneca PLC	100.00	2
BNTX	BioNTech SE	100.00	1	['customer', 'supplier']
TLX	Telix Pharmaceuticals Limited	100.00	2
BSX	Boston Scientific Corporation	100.00	2
ATNM	Actinium Pharmaceuticals, Inc.	100.00	2
ORANY	ORANGE	100.00	1	['customer', 'supplier']
CATX	Perspective Therapeutics, Inc.	100.00	2
BMYMP	Bristol-Myers Squibb Co	100.00	2
NBTX	Nanobiotix S.A.	100.00	2
LLY	Eli Lilly and Company	100.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
CBIO	Crescent Biopharma, Inc.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2

Matinas BioPharma Holdings, Inc. Supply Chain